Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Implants Type & End-User The global breast reconstruction market will notice a robust CAGR of 7.11%, valued at $2.87 billion in 2022, and poised to appreciate and reach $4.98 billion by 2030, confirms SMR. North America held the lion’s share in the breast reconstruction industry, with 39.98% in 2021. North America dominates the sector with increased investments in R&D, breast cancer awareness, and surgical advancements. Breast reconstruction surgery creates a new breast shape, usually using an implant or tissue from another body part. It can be done after a whole or part of the breast is removed. Breast reconstruction surgery is often done after breast cancer surgery to treat or prevent the spread of the disease. It is used by healthcare practitioners to contour breasts and restore damaged or missing tissue. This procedure is also used to regain the shape of the breast. By undergoing this surgery, the size and shape of the breast can be restored. Data published by breast cancer.org estimated that in the United States, approximately 287,857 new invasive breast cancer and about 51,400 new non-invasive breast cancer would be detected in women in 2022. Additionally, in the same year, nearly 2,710 new invasive breast cancers were estimated to be diagnosed in men. As per The American Cancer Society, among all reconstruction procedures in 2016, there were approximately 109,256 breast reconstruction surgeries performed. Breast reconstruction has had consistent annual growth over the years, with a 39% increase in the number of procedures since the year 2000 and a 3% boost since 2015. In 2021, hospitals generated the highest revenue share of more than 45% due to the growing number of hospitals around the world. Ambulatory surgery centres are likewise expected to increase at the quickest rate, at 8.7%. This is due to a rise in the number of breast reconstruction procedures. As per the Plastic Surgery Statistics Report, about 1,692,717 breast reconstruction procedures were conducted in ASCs. Breast reconstruction is the surgical process of rebuilding the shape and looks of the breast. It is performed among women who previously had undergone breast cancer surgeries. In addition, it inculcates the implementation of autologous tissue, prosthetic implants, or a combination of both to reconstruct a natural-looking breast. According to WHO (World Health Organization), in 2020, 2.3 million women worldwide were diagnosed with breast cancer resulting in 6,85,000 deaths. Also, in 2020, approximately 7.8 million women diagnosed with breast cancer were alive over the last five years, making it one of the world’s most prevalent types of cancer. According to CDC (Centers for Disease Control and Prevention), in the United States, approximately 255,000 breast cancer cases are diagnosed in women and 2300 in men yearly. Also, according to the American Society of Plastic Surgeons, more than 3.1 million people have successfully survived breast cancer in the United States. Unfortunately, each year across the globe, less than 50 percent of the women who require proper mastectomy are provided with the best breast reconstruction surgeries. In addition, less than 20% of women decide to undergo immediate reconstruction. TRAM (Transverse Rectus Abdominis)is a muscle that lies in the lower abdomen between the pubic bone and waist. A flap of this skin and part of the underlying rectus abdominus muscle are widely used for breast reconstruction surgeries. An abdominal flap is a tissue extracted from the abdomen by breast surgeons for breast reconstruction surgeries among women with extra abdominal tissues. It can also be implemented widely as a free flap. Nipple tattooing is an effective breast reconstruction procedure in which a tattoo artist reconstructs the nipple after the breast surgery has been performed. Breast reduction plasty is defined as a plastic surgery method for reconstructing the size of large breasts and is also used to ensure proper lactation capability and functional sensitivity of the breasts. The market for plastic surgery is growing widely with a CAGR of 6.11%, which is likely to propel the overall market growth. COVID-19 Impact The COVID-19 outbreak had a considerable impact on the current and future growth rate of the market. This unexpected situation has severely challenged breast and plastic surgeons, policymakers, and healthcare decision-makers. However, the COVID-19 pandemic has forced breast surgical teams worldwide to adapt to the new conditions for women having breast cancer that requires reconstruction. Key Drivers - Rising Numbers of Breast Cancers and Advancements in Technologies Related to Breast Cancer Treatment Will Drive the Market’s Growth. The rising prevalence of breast cancer worldwide is one of the significant causes, propelling the overall market growth worldwide. At least 1 out of 8 women (approx. 13.14%) in the United States develop invasive breast cancer over the due course of her lifetime. Also, the advancement in technologies and rise in demand for the various breast reconstruction surgical processes like Nipple-Areola Complex (NAC) Reconstruction, Nipple Prosthesis, Mammoplasty, Mastopexy, Radical mastectomy, Lumpectomy Nipple Grafting, Breast lift, Free flap breast reconstruction, Delayed Reconstruction, Implant-Based Reconstruction, and Flap-Based Reconstruction are fuelling the overall market growth. Apart from the rise in the demand for various breast reconstruction surgeries, the increasing demand for Local Tissue Flaps with the Use of AlloDerm, and other breast screening technologies like Breast ultrasound, and Automated whole-breast ultrasound, are stimulating the Global Breast Cancer Screening Market. As a result, the market will grow at a CAGR of 5.03%, which leads to the growth of the global breast reconstruction market. Restraints - The High Cost of Surgical Procedures, Infections After Surgeries, And the Development of Breast Cancer Detection Techniques Will Rest the Market’s Growth. Infections, capsular contracture, somatosensory loss, upper quarter dysfunction, and lymphedema are the main reasons obstructing the overall market growth. High cost is also one of the significant factors that are restraining the overall market growth. Typically, breast reconstruction surgery costs around USD 25,000 to USD 50,000 or even more than that per breast, and approximately USD 50,000 to USD 100,000 for both breasts. The development of various image detection tests for early stages of breast cancer like Mammography, Tomosynthesis, Xeromammography, Galactography, Breast MRI, Scintimammography, Elastography, Breast biopsy, etc. will decrease the probability of going through the surgical procedures for breast reconstruction will widely restrain the overall market growth. Opportunities - The Increasing Popularity of Skin-sparing Mastectomy Skin-sparing mastectomy continues to gain popularity globally and has nearly approached as a standard of care status in the field of breast reconstruction. It is estimated to grow exponentially in the upcoming future. Market Analysis Of Different Segments Covered in the Report Based on Type: Implants Saline Implants Silicone Implants Tissue Expander Based on End-User Hospitals Ambulatory Surgical Centers Cosmetology Clinics Regional Coverage Analysis North America US Mexico Canada Rest of North America Europe Finland Switzerland Russia France Germany U.K Turkey Netherlands Belgium Spain Italy Rest of Europe Asia Pacific China India Japan Thailand Malaysia Singapore South Korea Indonesia Philippines Australia Rest of Asia-Pacific LAMEA Brazil Argentina Uruguay Saudi Arabia Rest of LAMEA Based on Type, the ‘Implants’ segment dominated the market with an overall CAGR of 5.78 % and a total market share of USD 1.41 billion in 2020. An abrupt increase in breast cancer cases and the rising prevalence of breast implant procedures are widely fuelling the growth of this segment. Based on End-User, the ‘Hospitals’ segment dominated the market with a CAGR of 6.41%. In hospitals, Approximately 66.7% of the total breast reconstruction surgeries are conducted. About 500 men and 42,000 women die yearly in the United States due to breast cancer. Based on Regions, Due to the steadily increasing number of breast cancer cases, North America held a promising market share of 39.98% for breast reconstruction in 2021. Breast cancer is one of the most recurrent cancers among females in North America, leading to a proliferating demand for breast reconstruction applications. A study suggests that 300,000 new breast cancer cases are registered annually in North America. Increased awareness and access to reconstruction options have resulted in more women seeking the same. Advancements in reconstructive techniques, multidisciplinary approach, patient-centered care, psychosocial and emotional benefits, technological advances, increased awareness, improved access to reconstructive options, insurance coverage, surgical procedures, and the overall focus on patient-centered care have all bestowed to the expansion of the breast reconstruction market in North America. The presence of leading breast construction market players in North America has led to the region’s dominance. Breast Reconstruction Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 2.68 Billion The revenue forecast in 2030 USD 4.98 Billion Growth rate CAGR of approximately 7.11% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation Based on Type, Based on End-User, Based on Regions. Based on Type Implants (Saline Implants, Silicone Implants), Tissue Expander. Based on End-User Hospitals, Ambulatory Surgical Centers, Cosmetology Clinics. Market Breakup by Geography North America, Europe, Asia Pacific, LAMIA. Country Scope U.S, Canada, France, Germany, U.K, China, Japan, India, South Korea, Mexico, Brazil, U.A.E., etc. Company Usability Profiles Mentor Worldwide LLC, Allergan Inc., Johnson & Johnson, SientraInc., GC Aesthetics, Ideal Implant Incorporated, POLYTECH Health & Aesthetics GmbH, CEREPLAS, AbbVie Inc., PMT Corporation, Establishment Labs S.A., Arion Laboratories, AirXpanders, Integra Lifesciences, DPS Technology Development Ltd, Wanhe, KOKEN CO. LTD., HANSBIOMED CO. LTD, Sebbin. Pricing and purchase options Avail of customized purchase options to meet your exact research needs. Global Breast Reconstruction Competitive Landscape Analysis Competitive landscape analysis is implemented to figure out the key market competitors worldwide. The comparison is solely performed based on the total expenditure in R&D, the overall capability of the market, market initiatives, global presence, company overview and financials, revenue generation, production facilities and sites, the capacity of production, organization flaws, and strengths, etc. Mentor Worldwide LLC Allergan Inc. Johnson & Johnson SientraInc. GC Aesthetics Ideal Implant Incorporated POLYTECH Health & Aesthetics GmbH CEREPLAS AbbVie Inc. PMT Corporation Establishment Labs S.A. Arion Laboratories AirXpanders Integra Lifesciences DPS Technology Development Ltd Wanhe KOKEN CO. LTD. HANSBIOMED CO. LTD Sebbin Recent Developments On April 2023, an Israeli 3D printing company, Stratasys & CollPlant Technologies which is an American bioinks company, are collaborating to create the technology to 3D-print breast implants to aid patients in regenerating their natural breast tissue. The implants are made to replace lost biological breast tissue without triggering an immune reaction. CollPlant has successfully finished a large-animal study for its 3D bio-printed regenerative breast implants, and it intends to start a follow-up study in the second half of 2023 using commercial-size implants to support upcoming human studies. On October 2022, The LUNA xtTM was the first micro-textured anatomical breast implant to receive CE approval under the European Medical Device Regulation. Luna xtTM is developed by GC Aesthetics, and it offers an industry-leading response to surgeon and patient needs in breast reconstruction procedures. On August 2022, 3D printed Scaffolds were created by Australian researchers using additive manufacturing techniques, eventually taking the place of traditional silicone breast implants. The scaffold is made of the same material as dissolvable stitches and resembles a traditional implant. The research group anticipates this technology will transform breast reconstruction and cosmetic surgery procedures. The Essential Products Developed by the Market Leaders Name of the product Function Company Name Integra Breast Expanders Provides a lower pole projection for creating a more natural anatomical expansion of the breast. PMT Corporation ARTIA A reconstructive tissue matrix that widely facilitates breast reconstruction surgeries. AbbVie Inc Memory Gel Breast Implants Indicates the requirement of Breast Augmentation in women of at least 22 years of age Johnson & Johnson Frequently Asked Question About This Report Which are the most notable competitors in the global market? The most notable competitors in the global market are Mentor Worldwide LLC, Allergan Inc, Johnson & Johnson Services Inc, Sientra Inc, GC Aesthetics, Ideal Implant Incorporated, POLYTECH Health & Aesthetics GmbH, CEREPLAS, AbbVie Inc, PMT Corporation, Establishment Labs S.A., Arion Laboratories, AirXpanders, Integra Lifesciences, DPS Technology Development Ltd, Wanhe, KOKEN CO. LTD, HANSBIOMED CO. LTD, Sebbin, etc. How big is the breast reconstruction market? The global breast reconstruction market size was $2.68 Bn in 2021 and is predicted to reach $4.98 Bn by 2030, with a CAGR of 7.11%. What is the breast reconstruction market growth? The global breast reconstruction market is expected to grow at a compound annual growth rate (CAGR) of 7.11% from 2021 to 2030 to reach USD 4.98 billion by 2030. What are the different types of new trends and advancements in the market? Microvascular free flap breast reconstruction, autologous free flap breast reconstruction, and acellular dermal matrices are significant trends and advancements in the market. Which segment has the highest market share? The ‘Implants’ segment accounted for the highest market share. What are the various pivotal factors that are driving the market? The rising prevalence of breast cancer all around the world, increase in demand for breast reconstruction surgical procedures, breast cancer screening, local tissue flaps with use of alloderm are some of the pivotal breast screening technologies which are propelling the growth of the market. What are the different processes of breast reconstruction surgeries in the market? The different processes of breast reconstruction surgeries in the market are nipple-areola complex (nac) reconstruction, breast lift, nipple prosthesis, mammoplasty, mastopexy, radical mastectomy, lumpectomy, nipple grafting, free flap breast reconstruction,delayed reconstruction, implant-based reconstruction, and flap-based reconstruction. What are the different image tests conducted to detect early breast cancer in the global market? The different image tests that are conducted for the detection of early breast cancer in the global market are mammography, tomosynthesis, xeromammography, galactography, breast MRI, scintimammography, elastography, breast biopsy, etc. Sources https://www.who.int/news-room/fact-sheets/detail/breast-cancer https://www.cdc.gov/cancer/breast/basic_info/index.htm https://www.plasticsurgery.org/news/blog/new-plastic-surgery-statistics-and-breast-reconstruction-trends https://www.ncbi.nlm.nih.gov/books/NBK482286/ https://health.costhelper.com/breast-reconstruction.html https://www.businesswire.com/news/home/20221003005421/en/ https://nocamels.com/2023/04/breast-implants-3d-printed-with-israeli-tech/ https://www.3dnatives.com/en/3d-printed-scaffold-breast-implants-090820225/# https://www.breastcancer.org/facts-statistics https://www.ncbi.nlm..nih.gov/pmc/ https://www.lc-plasticsurgery.com/read-about-us/blog/2022/5/26/these-recent-advances-have-improved-breast-reconstruction-treatment/ https://www.strategicmarketresearch.com/market-report/breast-reconstruction-market Chapter 1. Introduction 1.1 Study Objectives 1.2 Market Definition Table 1 Inclusions and Exclusions 1.3 Study Scope 1.3.1 Markets Covered Figure 01: Segmentation 1.3.2 Geographic Scope Figure 02: Geography covered 1.3.3 Years Considered 1.4 Stakeholders Chapter 2. Research Methodology 2.1 Data Procurement 2.2 Paid Database 2.2.1 Secondary Data 2.2.1.1 Key Secondary sources 2.2.2 Primary Data 2.2.2.1 Primary sources 2.2.2.2 Key industry insights 2.2.2.3 Primary interviews with experts 2.2.2.4 Key primary respondent list 2.3 Market Size Estimation 2.4 Bottom-Up and Top-Down Approaches 2.4.1 Bottom-Up Approach 2.4.1.1 Approach for arriving at market size by bottom-up analysis Figure 03:: Bottom-Up Approach 2.4.2 Top-Down Approach 2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis Figure 04:: Top-Down Approach 2.5 Market Breakdown and Data Triangulation Figure 05: Data Triangulation 2.6 Research Methodology 2.7 Risk Assessment Table 2: Risk Assessment Chapter 3. Executive Summary 3.1: Post-Covid-19 Figure 06: Impact of Covid-19 on 3.1.1 Actual Scenario Figure 07: Realistic Scenario: 2020–2030 (USD Million) 3.1.2 Pessimistic Scenario Figure 08: Pessimistic Scenario: 2020–2030 (USD Million) 3.1.3 Optimistic Scenario Figure 09: Optimistic Scenario: 2020–2030(USD Million) 3.1.4 Market Summary Figure 10: Implants to Witness Highest CAGR in, By Type, During Forecast Period Figure 11: Hospitals' Higher CAGR for End-User Segment during Forecast Period Figure 12: North America to Account for Largest Share In 2020 Chapter 4. Market Definitions 4.1 Market Segmentation Figure 13: Segmentation Chapter 5. Industry Outlook 5.1 Market Snapshot 5.2 Global Breast Reconstruction Market 5.2.1 Market, 2020 – 2030 (USD Million) 5.3 Regional Segment Analysis 5.3.1 Market, by region, 2021-2030 (USD Million) 5.4 Type Segment Analysis 5.4.1 Market, by Type, 2021-2030 (USD Million) 5.5 End-User Segment Analysis 5.5.1 Market, By End-User, 2021-2030 (USD Million) 5.6 Value Chain Analysis 5.7 Market Variable Analysis 5.7.1 Market Drivers Analysis 5.7.2 Market Restraints Analysis 5.8 Business Environment Analysis Tool 5.8.1 PEST analysis 5.8.2 Porter’s analysis 5.9 Penetration & Growth Prospect Mapping Chapter 6. Market Overview 6.1 Introduction 6.2 Market Dynamics Figure 14 : Drivers, Restraints, Opportunities, and Challenges 6.2.1 Drivers Figure 15 Drivers and Their Impact 6.2.2 Restraints Figure 16 Restraints and Their Impact 6.2.3 Opportunities Figure 17 Opportunities and Their Impact 6.2.4 Challenges Figure 18 Challenges and Their Impact 6.3 Impact of Covid-19 on 6.4 Value Chain Analysis Figure 19 Value Chain Analysis: 6.5 Ecosystem Figure 20 : Ecosystem Table 3 : Ecosystem Figure 21 Revenue Shift in 6.6 Patent Analysis Table 4 Number of Patents Registered in USA in Last 9 Years Figure 22 Top 19 Companies with Highest No. of Patents in Last 9 Years Figure 23 No of Patents Granted Per Year, 2019–2020 Table 5 List of Global Patents in 6.7 Trade Analysis Figure 24 Import Data for Implants, By Country, 2016–2020 (USD Thousand) Table 6 Import Data for Saline Implants, By Country, 2016–2020 (USD Thousand) Figure 25 Import Data for Silicone Implants, By Country, 2016–2020 (USD Thousand) Table 7 Import Data for Tissue Expander, By Country, 2016–2020 (USD Thousand) Figure 26 Export Data for Implants, By Country, 2016–2020 (USD Thousand) Table 8 Export Data for Saline Implants, By Country, 2016–2020 (USD Thousand) Figure 27 Export Data for Silicone Implants, By Country, 2016–2020 (USD Thousand) Table 9 Export Data for Tissue Expander, By Country, 2016–2020 (USD Thousand) 6.8 Tariff Analysis 6.9 Case Study Analysis 6.10 Porter’s Five Forces Analysis Table 10: Porter’s Five Forces Analysis, 2020 6.10.1 Threat of New Entrants 6.10.2 Threat of Substitutes 6.10.3 Bargaining Power of Buyers 6.10.4 Bargaining Power of Suppliers 6.10.5 Degree of Competition 6.11 Technology Analysis 6.11.1 Trends in Technology (2014-2020) 6.11.2 Trends in Technology (2021-2030) Table 11 Key Regulations: 6.12 Pricing Analysis 6.12.1 Average Price Trend Analysis (By Region, By Country) Chapter 7. Competitive & Vendor Landscape 7.1 Company Market Share Analysis Table 12: Key Player's market share Figure 28: Key player's market share of companies 7.2 Manufacturers Breast Reconstruction Manufacturing Sites, Area Served, Product Type 7.3 Competitive Situation and Trends 7.4 Manufacturers Mergers & Acquisitions, Expansion Plans Chapter 8. Market: Type Segment Analysis 8.1 Introduction 8.2 Sales Volume & Revenue Analysis (2021-2030) Table 13 Market, By Type, 2021–2030 (USD Million) Figure 29 Market, By Type Figure 30 Implants Segment to Register Highest CAGR in During Forecast Period 8.3 Implants 8.3.1 Implants market, 2021-2030 (USD Million) Figure 31: Abdominal Aortic Aneurysm market, 2021-2030 (USD Million) 8.4 Saline Implants 8.4.1 Saline Implants market, 2021-2030 (USD Million) Figure 32: Saline Implants market, 2021-2030 (USD Million) 8.5 Silicone Implants 8.5.1 Silicone Implants market, 2021-2030 (USD Million) Figure 33: Silicone Implants market, 2021-2030 (USD Million) 8.6 Tissue Expander 8.6.1 Tissue Expander market, 2021-2030 (USD Million) Figure 34: Tissue Expander market, 2021-2030 (USD Million) Chapter 9. Global: End-User Segment Analysis 9.1 Introduction 9.2 Sales Volume & Revenue Analysis (2021-2030) Table 14: Market, By End-User, 2021–2030 (USD Million) Figure 35: Market, By End-User, 2021–2030 (USD Million) Figure 36: Hospitals Segment to Register Highest CAGR in during Forecast Period 9.3 Hospitals 9.3.1 Hospitals market, 2021-2030 (USD Million) Figure 37: Hospitals market, 2021-2030 (USD Million) 9.4 Cosmetology Clinics 9.4.1 Cosmetology Clinics market, 2021-2030 (USD Million) Figure 38: Cosmetology Clinics market, 2021-2030 (USD Million) 9.5 Ambulatory Surgical Centers 9.5.1 Ambulatory Surgical Centers market, 2021-2030 (USD Million) Figure 39: Ambulatory Surgical Centers market, 2021-2030 (USD Million) 9.7 Others 9.7.1 Others market, 2021-2030 (USD Million) Figure 40: Others market, 2021-2030 (USD Million) Chapter 10. Global: Regional Outlook 10.1 North America Figure 41: North America , By Revenue Forecast (2021-2030) 10.1.1 North America , by country, 2021-2030 (USD Million) Table 15: North America , by Country, 2021-2030 Figure 42: North America 10.1.2 North America , by Type, 2021-2030 (USD Million) Table16: North America , by Type, 2021-2030 (USD Million) Figure 43: North America , by Type, 2021-2030 (USD Million) 10.1.3 North America , by End-User, 2021-2030 (USD Million) Table 17: North America , by End-User, 2021-2030 (USD Million) Figure 44: North America , by End-User, 2021-2030 (USD Million) 10.1.4 U.S. 10.1.4.1 U.S. , by Type, 2021-2030 (USD Million) Figure 45: U.S. , by Type, 2021-2030 (USD Million) 10.1.4.2 U.S. , by End-User, 2021-2030 (USD Million) Figure 46: U.S. , by End-User, 2021-2030 (USD Million) 10.1.5 Canada 10.1.5.1 Canada , by Type, 2021-2030 (USD Million) Figure 47: Canada , by Type, 2021-2030 (USD Million) 10.1.5.2 Canada , by End-User, 2021-2030 (USD Million) Figure 48: Canada , by End-User, 2021-2030 (USD Million) Figure 49: Canada , by End-User, 2021-2030 (USD Million) Figure 50: Canada , by End-User, 2021-2030 (USD Million) 10.2 Europe Figure 51: Europe , By Revenue Forecast (2021-2030) 10.2.1 Europe , by country, 2021-2030 (USD Million) Table 18: Europe , by country, 2021-2030 (USD Million) Figure 52: Europe , by country, 2021-2030 (USD Million) 10.2.2 Europe , by Type, 2021-2030 (USD Million) Table 19: Europe , by Type, 2021-2030 (USD Million) Figure 53: Europe , by Type, 2021-2030 (USD Million) 10.2.3 Europe , by End-User, 2021-2030 (USD Million) Table 20: Europe , by End-User, 2021-2030 (USD Million) Figure 54: Europe , by End-User, 2021-2030 (USD Million) 10.2.4 U.K. 10.2.4.1 U.K. , by Type, 2021-2030 (USD Million) Figure 55: U.K. , by Type, 2021-2030 (USD Million) 10.2.4.2 U.K. , by End-User, 2021-2030 (USD Million) Figure 56: U.K. , by End-User, 2021-2030 (USD Million) 10.2.5 Germany 10.2.5.1 Germany , by Type, 2021-2030 (USD Million) Figure 57: Germany , by Type, 2021-2030 (USD Million) 10.2.5.2 Germany , by End-User, 2021-2030 (USD Million) Figure 58: Germany , by End-User, 2021-2030 (USD Million) 10.2.6 France 10.2.6.1 France , by Type, 2021-2030 (USD Million) Figure 59: France , by Type, 2021-2030 (USD Million) 10.2.6.2 France , by End-User, 2021-2030 (USD Million) Figure 60: France , by End-User, 2021-2030 (USD Million) 10.2.7 Rest of Europe 10.2.7.1 Rest of Europe , by Type, 2021-2030 (USD Million) Figure 61: Rest of Europe , by Type, 2021-2030 (USD Million) 10.2.7.2 Rest of Europe , by End-User, 2021-2030 (USD Million) Figure 62: Rest of Europe , by End-User, 2021-2030 (USD Million) 10.3 Asia Pacific Figure 63: Asia Pacific , By Revenue Forecast (2021-2030) 10.3.1 Asia Pacific , by country, 2021-2030 (USD Million) Table 21: Asia Pacific , by country, 2021-2030 (USD Million) Figure 64: Asia Pacific , by country, 2021-2030 (USD Million) 10.3.2 Asia Pacific , by Type, 2021-2030 (USD Million) Table 22: Asia Pacific , by Type, 2021-2030 (USD Million) Figure 65: Asia Pacific , by Type, 2021-2030 (USD Million) 10.3.3 Asia Pacific , by End-User, 2021-2030 (USD Million) Table 23: Asia Pacific , by End-User, 2021-2030 (USD Million) Figure 66: Asia Pacific , by End-User, 2021-2030 (USD Million) 10.3.4 China 10.3.4.1 China , by Type, 2021-2030 (USD Million) Figure 67: China , by Type, 2021-2030 (USD Million) 10.3.4.2 China , by End-User, 2021-2030 (USD Million) Figure 68: China , by End-User, 2021-2030 (USD Million) 10.3.5 India 10.3.5.1 India , by Type, 2021-2030 (USD Million) Figure 69: India , by Type, 2021-2030 (USD Million) 10.3.5.2 India , by End-User, 2021-2030 (USD Million) Figure 70: India , by End-User, 2021-2030 (USD Million) 10.3.6 Japan 10.3.6.1 Japan , by Type, 2021-2030 (USD Million) Figure 71: Japan , by Type, 2021-2030 (USD Million) 10.3.6.2 Japan , by End-User, 2021-2030 (USD Million) Figure 72: Japan , by End-User, 2021-2030 (USD Million) 10.3.7 South Korea 10.3.7.1 South Korea , by Type, 2021-2030 (USD Million) Figure 73: South Korea , by Type, 2021-2030 (USD Million) 10.3.7.2 South Korea , by End-User, 2021-2030 (USD Million) Figure 74: South Korea , by End-User, 2021-2030 (USD Million) 10.3.8 Rest of APAC 10.3.8.1 Rest of APAC , by Type, 2021-2030 (USD Million) Figure 75: Rest of APAC , by Type, 2021-2030 (USD Million) 10.3.8.2 Rest of APAC , by End-User, 2021-2030 (USD Million) Figure 76: Rest of APAC , by End-User, 2021-2030 (USD Million) 10.4 Latin America Figure 77: Latin America , By Revenue Forecast (2021-2030) 10.4.1 Latin America , by country, 2021-2030 (USD Million) Table 24: Latin America , by country, 2021-2030 (USD Million) Figure 78: Latin America , by country, 2021-2030 (USD Million) 10.4.2 Latin America , by Type, 2021-2030 (USD Million) Table 25: Latin America , by Type, 2021-2030 (USD Million) Figure 79: Latin America , by Type, 2021-2030 (USD Million) 10.4.3 Latin America , by End-User, 2021-2030 (USD Million) Table 26: Latin America , by End-User, 2021-2030 (USD Million) Figure 80: Latin America , by End-User, 2021-2030 (USD Million) 10.4.4 Brazil 10.4.4.1 Brazil , by Type, 2021-2030 (USD Million) Figure 81: Brazil , by Type, 2021-2030 (USD Million) 10.4.4.2 Brazil , by End-User, 2021-2030 (USD Million) Figure 82: Brazil , by End-User, 2021-2030 (USD Million) 10.4.5 Mexico 10.4.5.1 Mexico , by Type, 2021-2030 (USD Million) Figure 83: Mexico , by Type, 2021-2030 (USD Million) 10.4.5 2 Mexico , by End-User, 2021-2030 (USD Million) Figure 84: Mexico , by End-User, 2021-2030 (USD Million) 10.4.6 Rest of the Latin America 10.4.6.1 Rest of the Latin America , by Type, 2021-2030 (USD Million) Figure 85: Rest of the Latin America , by Type, 2021-2030 (USD Million) 10.4.6.2 Rest of the Latin America , by End-User, 2021-2030 (USD Million) Figure 86: Rest of the Latin America , by End-User, 2021-2030 (USD Million) 10.5 MEA Figure 87: MEA , By Revenue Forecast (2021-2030) 10.5.1 MEA , by Type, 2021-2030 (USD Million) Figure 88: MEA , by Type, 2021-2030 (USD Million) 10.5.2 MEA , by End-User, 2021-2030 (USD Million) Figure 89: MEA , by End-User, 2021-2030 (USD Million) Chapter 11. Competitive Landscape 11.1 Mentor Worldwide LLC. 11.1.1 Company overview 11.1.2 Financial performance 11.1.3 Product Portfolio Analysis 11.1.4 Business Strategy & Recent Development 11.2 Allergan Inc. 11.2.1 Company overview 11.2.2 Financial performance 11.2.3 Product Portfolio Analysis 11.2.4 Business Strategy & Recent Development 11.3 Johnson & Johnson. 11.3.1 Company overview 11.3.2 Financial performance 11.3.3 Product Portfolio Analysis 11.3.4 Business Strategy & Recent Development 11.4 SientraInc. 11.4.1 Company overview 11.4.2 Financial performance 11.4.3 Product Portfolio Analysis 11.4.4 Business Strategy & Recent Development 11.5 GC Aesthetics. 11.5.1 Company overview 11.5.2 Financial performance 11.5.3 Product Portfolio Analysis 11.5.4 Business Strategy & Recent Development 11.6 Ideal Implant Incorporated. 11.6.1 Company overview 11.6.2 Financial performance 11.6.3 Product Portfolio Analysis 11.6.4 Business Strategy & Recent Development 11.7 POLYTECH Health & Aesthetics GmbH. 11.7.1 Company overview 11.7.2 Financial performance 11.7.3 Product Portfolio Analysis 11.7.4 Business Strategy & Recent Development 11.8 CEREPLAS. 11.8.1 Company overview 11.8.2 Financial performance 11.8.3 Product Portfolio Analysis 11.8.4 Business Strategy & Recent Development 11.9 AbbVie Inc. 11.9.1 Company overview 11.9.2 Financial performance 11.9.3 Product Portfolio Analysis 11.9.4 Business Strategy & Recent Development 11.10 PMT Corporation. 11.10.1 Company overview 11.10.2 Financial performance 11.10.3 Product Portfolio Analysis 11.10.4 Business Strategy & Recent Development 11.11 Establishment Labs S.A. 11.11.1 Company overview 11.11.2 Financial performance 11.11.3 Product Portfolio Analysis 11.11.4 Business Strategy & Recent Development 11.12 Arion Laboratories. 11.12.1 Company overview 11.12.2 Financial performance 11.12.3 Product Portfolio Analysis 11.12.4 Business Strategy & Recent Development 11.13 AirXpanders. 11.13.1 Company overview 11.13.2 Financial performance 11.13.3 Product Portfolio Analysis 11.13.4 Business Strategy & Recent Development 11.14 Integra Life sciences. 11.14.1 Company overview 11.14.2 Financial performance 11.14.3 Product Portfolio Analysis 11.14.4 Business Strategy & Recent Development 11.15 DPS Technology Development Ltd. 11.15.1 Company overview 11.15.2 Financial performance 11.15.3 Product Portfolio Analysis 11.15.4 Business Strategy & Recent Development 11.16 Wanhe. 11.16.1 Company overview 11.16.2 Financial performance 11.16.3 Product Portfolio Analysis 11.16.4 Business Strategy & Recent Development 11.17 KOKEN CO. LTD. 11.17.1 Company overview 11.17.2 Financial performance 11.17.3 Product Portfolio Analysis 11.17.4 Business Strategy & Recent Development 11.18 HANSBIOMED CO. LTD. 11.18.1 Company overview 11.18.2 Financial performance 11.18.3 Product Portfolio Analysis 11.18.4 Business Strategy & Recent Development 11.19 Sebbin. 11.19.1 Company overview 11.19.2 Financial performance 11.19.3 Product Portfolio Analysis 11.19.4 Business Strategy & Recent Development